291650 — Aptamer Sciences Balance Sheet
0.000.00%
- KR₩31bn
- KR₩16bn
- KR₩1bn
Annual balance sheet for Aptamer Sciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 34,863 | 24,209 | 34,722 | 23,737 | 17,474 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 125 | 183 | 604 | 481 | 1,059 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 35,308 | 24,815 | 37,964 | 25,034 | 18,833 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 735 | 7,540 | 7,441 | 7,251 | 10,981 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 36,933 | 33,262 | 45,645 | 32,536 | 31,981 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 593 | 432 | 2,538 | 15,239 | 3,895 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,749 | 1,800 | 16,423 | 17,057 | 6,545 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Total Equity | 35,184 | 31,461 | 29,223 | 15,479 | 25,436 |
Total Liabilities & Shareholders' Equity | 36,933 | 33,262 | 45,645 | 32,536 | 31,981 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |